NEONC TECHNOLOGIES HOLDINGS, INC. - 8-K Filing
NeOnc CEO Amir Heshmatpour purchases 80,000 shares as FDA grants Type B End-of-Phase meeting for NEO100 accelerated approval pathway (Items: 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)